Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血
数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血
数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受
血细胞计数检查,以监测骨髓发育不良
继发性白血病的发
迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动,
分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞
查,以监测骨髓发育不良
继发性白血病的发生迹
。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,因临床标本采集和运输不当造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者
治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病
发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床本采集和运输不当造
本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷
治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病
发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检
,
测骨髓
育不良
继
性白血病的
象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量问题占72。
声明:上例句、词性分类均由互联网资源自动
成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若
现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
苷
者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓发育不良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输不当造成的标本质量72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的治疗应该每年接受全血细胞计数检查,以监测骨髓
白血病的
生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运输当造成的标本质量问题占72。
声明:以上例句、词分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦
代表本软件的观点;若
现问题,欢迎向我们指正。
Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.
依托泊苷者烷化剂的
该每年接受全血细胞计数检查,以监测骨髓发育
良
继发性白血病的发生迹象。
We find that unqualified specimen because of poor quality control of preanalysis account for 9 40%.of total complete blood count specimen.
40%,其中因临床标本采集和运造成的标本质量问题占72。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦代表本软件的观点;若发现问题,欢迎向我们指正。